Seth Klarman

Seth Klarman

Last Update: 2014-08-14

Number of Stocks: 24
Number of New Stocks: 4

Total Value: $6,141 Mil
Q/Q Turnover: 9%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Seth Klarman Watch

  • Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sells BP, Theravance

    Legendary value investor, hedge fund manager Seth Klarman (Trades, Portfolio) just reported his second quarter portfolio. Seth Klarman (Trades, Portfolio) buys eBay Inc, SunEdison Semiconductor Ltd, Keryx Biopharmaceuticals Inc, Kosmos Energy Ltd, Boyd Gaming Corporation, Triquint Semiconductor, RF Micro Devices Inc, Cheniere Energy Inc, Viasat Inc, Veritiv Corp, Veritiv Corp, sells BP PLC, Theravance Inc during the 3-months ended 06/30/2014, according to the most recent filings of his investment company, The Baupost Group. As of 06/30/2014, The Baupost Group owns 24 stocks with a total value of $6.1 billion. These are the details of the buys and sells.  

  • Seth Klarman Buys 14% of Newly Formed Company Veritiv

    Seth Klarman (Trades, Portfolio), the value-driven founder of the Baupost Group, purchased 2,249,601 shares of Veritiv Corp. (VRTV), according to GuruFocus Real Time Picks. His holding represents 14.06% of the company, a filing from July 31 showed.

    Veritiv’s stock began trading on the New York Stock Exchange in June, and its price has declined by 2.35% since. The price closed at $39.92 the date Klarman reported buying the stock, which is off of its 52-week high of $51.


  • Seth Klarman Is Top-Performing Guru for First Half 2014

    After making a $1 billion gain on Idenix Pharmaceuticals Inc. (IDIX) and his stock picks of the past six months on average gaining 60.8% in the first half of the year compared to about 6% for the S&P 500, Seth Karman resoundingly leads GuruFocus’ scoreboard.

    Seth Klarman (Trades, Portfolio), founder of $27 billion Boston-based Baupost Group, has a strictly value strategy wherein he seeks a large margin of safety and often picks “cigar-butt” companies, which is working beautifully this year. Three of his new first-quarter stocks have appreciated more than 50% from the quarter’s average price. Two of three of his fourth quarter 2013 picks are up 26% and 58% since he bought.


  • Seth Klarman Buys Cheniere Energy, Keryx Biopharmaceuticals, Idenix Pharmaceuticals, Sells BP, Fidelity National Financial

    The Baupost Group, the hedge fund firm run by famed investor Seth Klarman (Trades, Portfolio), just reported their first quarter portfolio. Seth Klarman (Trades, Portfolio) buys Cheniere Energy Inc, Keryx Biopharmaceuticals Inc, Idenix Pharmaceuticals Inc, PBF Energy Inc, RF Micro Devices Inc, Triquint Semiconductor, Viasat Inc, Theravance Inc, Keryx Biopharmaceuticals Inc, sells BP PLC, Fidelity National Financial Inc, Rovi Corp, Enzon Pharmaceuticals Inc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, The Baupost Group. As of 03/31/2014, The Baupost Group owns 20 stocks with a total value of $4.1 billion. These are the details of the buys and sells.


  • Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals

    The Baupost Group’s Seth Klarman (Trades, Portfolio) has purchased a new holding that constitutes more than 5% of the company, requiring reporting during the quarter and appearing on GuruFocus RealTime Picks. The purchase was of 9,151,600 shares of Keryx Biopharmaceuticals (KERX), which represents 10.07% of the company’s shares outstanding.

    Klarman made the transaction on April 30, when shares averaged $14.35, making the transaction value $131,325,460. Over the past year, Keryx Biopharmaceuticals’ stock price has increased 55%, including a 5.2% jump on Monday.  

  • Invest Like Benjamin Graham in Singapore Stocks

    Benjamin Graham is the father of value investing and his way of value investing was to search for net-net stocks, and construct a basket of them as his portfolio. His method of value investing is still being widely practiced by value investors such as Seth Klarman (Trades, Portfolio), Third Avenue Management (Trades, Portfolio), etc. In this blog post, I would like to refer to an article by CLSA to explore the idea of investing in Graham-like stocks in the Singapore stock market.

    They construct a stock screen that incorporates the attributes that Ben Graham looks for in a undervalued stocks and run the stock screen through all the SGX stocks to find stocks that fulfill it. The end result of this stock screen is the Ben Graham Number.

  • Two Seth Klarman Stocks in His Top-Weighted Tech Sector Reach Five-Year Highs

    Seth Klarman (Trades, Portfolio), a renowned value investor at the Baupost Group, has a dire forecast for markets. In his 2013 annual letter, he said that he sees a “Truman Show” market which is precarious even though it doesn’t look that bad. He names as positive factors: elevated but not extreme P/E ratios, shrinking deficits, mending consumer balance sheets, recovering U.S. housing, nearing energy independence, low bond yields and low interest rates.

    He also sees negative trends looming: the consequences of near-zero short-term interest rates, Fed tapering, sizable deficits propping up the consumer, and a market higher only three times in the past based on Robert Schiller’s cyclically adjusted P/E ratio – prior to the past three market crashes.


  • The Choice Of A Discount Rate: Excerpts From Seth Klarman's 'Margin Of Safety'

    “Ultimately investors must choose sides. One side – the wrong choice is a seemingly effortless path that offers the comfort of consensus.” – Seth Klarman (Trades, Portfolio)

    I was fortunate enough to obtain a copy of Seth Klarman (Trades, Portfolio)’s "Margin of Safety" at the end of last week and read through most of it in one sitting. I found a few chapters very informative and worth sharing with others that may not have a copy themselves or have not read the book.


  • Inflation Is Coming, Inflation Is Coming!!

    Most know about the famous story of Paul Revere, the colonial patriot that rode from Boston to warn that the British troops were advancing upon the cities. Revere was the son of a silversmith and eventually was successful after the war as a silversmith himself. He also built the first copper mill and designed the original Continental currency. Less known is that Revere was with two other men on that famous ride, Samuel Prescott and William Dawes, who seem to appear only as footnotes in history, and are left out of the famous poem of that historic journey.

    Revere was captured before he could reach Concord, while it was Samuel Prescott that was actually the one able to complete the journey to Concord and warn the colonists. It is most probable that Revere and his compatriots actually yelled either, “The soldiers are coming” or “The redcoats are coming.” They were all mostly British, so to yell "The British are coming” would have perplexed all that heard the cry.


  • Tocqueville Asset Management - A Matter of Odds: Not Everything That Is Suppose to Work, Works All the Time

    The recent and ongoing confrontation between Russia and Ukraine over Crimea, with its saber rattling and flurry of diplomatic activity, has uncovered a lot of confusion about the causes, motives, and ultimate outcome of this crisis, as well as its likely economic and financial consequences.

    I cannot predict any of this. I was, however, able to make one high-conviction forecast early on: The crisis would trigger a bubble in experts on Russia, Ukraine, and Crimea. Indeed, the cocktail circuit, which is where people with more opinions than ideas meet to exchange peremptory platitudes, was promptly inundated with a tsunami of ready-made experts in history, Central European affairs, and geopolitical strategy.


  • John Mauldin's Outside the Box - Seth Klarman: Investors Downplaying Risk 'Never Turns Out Well'

    Seth Klarman (Trades, Portfolio): Investors Downplaying Risk “Never Turns Out Well”

    John Mauldin


  • What You Need to Look At to Find Exceptional Returns

    Pope Brar is a money manager based on the West Coast who has spent a considerable amount of time analyzing the success (as well as the failure) of some of the greatest investors.

    Brar has carefully examined the records of such legendary investors as Warren Buffett (Trades, Portfolio), Seth Klarman (Trades, Portfolio) and others to see what they have done to achieve such success over such a long time in the equity market.


  • Seth Klarman on His Book 'Margin of Safety'

  • A Classic 1991 Interview with Seth Klarman

  • Seth Klarman Buys New Stock Kindred Biosciences, Cuts Stake in Enzon

    Seth Klarman (Trades, Portfolio) of the Boston-based Baupost Group, which trades sparingly, has purchased a new stock: Kindred Biosciences (KIN), according to GuruFocus Real Time Picks.

    The purchase consisted of 2.9 million outstanding shares, giving Klarman 17.93% interest in the company. The transaction occurred on Dec. 31, 2013, when the price closed at $11.17 per share.


  • Seth Klarman's Low P/E Stocks

    The trademark of Seth Klarman’s investing style is low-priced stocks with a margin of safety. Therefore, it’s a good technique for investors to mine his portfolio for attractive investing ideas. A low P/E ratio often indicates an undervalued stock, and Klarman holds four companies trading at markedly low P/Es.

    The Stocks  

  • Seth Klarman Buys Refiner with Temporary Setbacks

    Seth Klarman in the third quarter purchased a classic Klarman stock – a company whose share price is struggling under the weight of major government regulation. The investor built his fortune at his Boston-based Baupost Group buying undervalued, low-risk equities and “cigar butts,” or stocks of declining businesses that might have a remaining bounce left in their stock price, and having utmost patience. In September, a dearth of suitable new investment opportunities led him to return some money to investors in order to keep his assets under management at his target $25 billion, according to Institutional Investor’s Alpha.

    The New Buy: PBF Energy (PBF)  

  • Seth Klarman Buys Micron Technology, Theravance, PBF Energy, Sells BP, AIG, Yamana Gold

    Renowned value investor Seth Klarman just reported his third quarter portfolio. He runs a very concentrated portfolio, with top two positions account for more than 50% of the stocks he owns. Seth Klarman buys Micron Technology, Inc., Theravance, Inc., PBF Energy Inc, Idenix Pharmaceuticals, Inc., Chipmos Technologies Bermuda Ltd., Idenix Pharmaceuticals, Inc., sells BP PLC, American International Group Inc, Yamana Gold Inc, Central Pacific Financial Corporation, Kinross Gold Corporation, Ituran Location and Control, Ltd., Alliance One International Inc, Pretium Resources, Inc. during the 3-months ended 09/30/2013, according to the most recent filings of his investment company, The Baupost Group.

    As of 09/30/2013, The Baupost Group owns 20 stocks with a total value of $3.5 billion. These are the details of the buys and sells.  

  • Seth Klarman Finds Margin of Safety in Drab Miners

    As an anti-momentum investor, Seth Klarman, founder of the Boston-based Baupost Group and author of the coveted out-of-print investing treatise “Margin of Safety,” can be expected to do the polar opposite of the broader market. His primary objective of avoiding risk drives him to out-of-favor sectors, where he picks stocks with a substantial margin of safety and waits as long as necessary for them to appreciate. Klarman has said, “Money is made when the crop is planted and not when it’s harvested.”

    It is no wonder then that he was buying mining companies in the second quarter. The S&P Metals and Mining ETF (SPSIMM) has declined more than 11% year to date. The broader Materials sector was also the second-poorest performing group of the S&P 500 year to date, returning 15.6%, compared to 23.9% for the overall market.  

  • Seth Klarman’s Top Growth Stocks

    The portfolio of Seth Klarman, the legendary value investor and portfolio manager of The Baupost Group, currently lists 24 stocks, five of them new, and a total value of $4.02 billion. His quarter-over-quarter turnover is 22%.

    Here are Klarman’s three stocks with the highest average 10-year EBITDA growth rates, as of June 30, 2013:  

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

ReplyJuandemarc - 3 weeks ago
I'm glad someone is following the finer details!
I agree, re- Seth Klarman (Trades, Portfolio) average price bought and sold , indeed would have made a loss on eg. Alere Inc.
The manor in which the data is presented anchors readers thoughts to a large gain of 70% rather than losses of circa 20-25%.
Current stock price does not equate to the value of the stock when sold!
This is a red herring data column and should be scrapped unless a true reflection of profit or loss on holdings is shown on both free and professional formats!
Great website although be careful of drawing false conclusions!
ReplyDrK - 1 month ago
The way you show "Gains" in the holding history of a guru makes absolutely no sense - you are calculating it as "price paid" vs. "current stock price". This is NOT the gain mthe Guru made, and can HIDE actual losses. Example: Seth Klarman (Trades, Portfolio) the way you calcute gain made more than 20% gain for the stock Alere Inc. (ALR) because you are comparing his price paid to the current stock price rather than to the price he sold out for. In reality he made a LOSS when selling it. THIS MUST BE CORRECTED - your information is misleading!
ReplyPaulmenezes - 1 month ago
Can we please have an update on performance here.
ReplyEfranco - 3 months ago
What does the ending ".WS" mean? thank you
ReplyPaulson545@yahoo - 4 months ago
There will soon be over 500 million diabetes world wide . It might be time to take a look at ( erb ) ERBA Diagnostics, a world wide company in the diabetic field.......jmho
ReplyToddforthree - 5 months ago
ReplyGoforit - 5 months ago
Why is your most recent performance data from 2001 - it's now 2014! How are we (and you) to rate Klarman when the most recent GuruFocus performance data is 13 years old? For all we know, his track record over the last 13 years could be 5% lower than the SP-500 index and yet he's listed as a Guru.
ReplyWsjalerts13 - 8 months ago
Rishardo - You are so smart
ReplyRishardo - 10 months ago
59% Tech weighting while the Nasdaq makes all time highs? This is going to end in tears.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial